R. Srivastava

发表

3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase.

M. Saquib, M. Siddiqi, P. Shah, 2015, Bioorganic chemistry.

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.

A. Saxena, M. Y. Krishnan, S. Jaiswal, 2015, Bioorganic & medicinal chemistry.

In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine infection model.

B. S. Srivastava, R. Shrivastava, G. Panda, 2012, The Journal of antimicrobial chemotherapy.

A transposon insertion mutant of Mycobacterium fortuitum attenuated in virulence and persistence in a murine infection model that is complemented by Rv3291c of Mycobacterium tuberculosis.

S. Srivastava, B. S. Srivastava, R. Shrivastava, 2008, Microbial pathogenesis.

beta-Galactosidase reporter system in mycobacteria and its application in rapid antimycobacterial drug screening.

B. S. Srivastava, R. Srivastava, D. Kumar, 1997, Biochemical and biophysical research communications.

Synthesis and antitubercular activities of bis-glycosylated diamino alcohols.

A. Gaikwad, A. Srivastava, B. S. Srivastava, 2005, Bioorganic & medicinal chemistry.

Murine infection model for Mycobacterium fortuitum.

S. Srivastava, R. Gachhui, R. Srivastava, 2005, Microbes and infection.

Mutation in tcpR gene (Vc0832) of Vibrio cholerae O1 causes loss of tolerance to high osmolarity and affects colonization and virulence in infant mice.

B. S. Srivastava, C. Pruzzo, A. Mishra, 2003, Journal of medical microbiology.

Protection by live Mycobacterium habana vaccine against Mycobacterium tuberculosis H37Rv challenge in mice.

B. S. Srivastava, S. Jain, R. Srivastava, 2003, The Indian journal of medical research.

Comparative expression analysis of rpf-like genes of Mycobacterium tuberculosis H37Rv under different physiological stress and growth conditions.

B. S. Srivastava, R. Gupta, R. Srivastava, 2010, Microbiology.

Functional characterization of VC1929 of Vibrio cholerae El Tor: role in mannose-sensitive haemagglutination, virulence and utilization of sialic acid.

B. S. Srivastava, S. Sharma, R. Srivastava, 2011, Microbiology.

Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits againstVibriocholerae

B. S. Srivastava, R. Mazumder, J. Kundu, 2009 .

Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains.

A. Dwivedi, V. Kashyap, R. Srivastava, 2013, Bioorganic & medicinal chemistry letters.

Selection of genes of Mycobacterium tuberculosis upregulated during residence in lungs of infected mice.

V. Srivastava, B. S. Srivastava, Anamika Jain, 2008, Tuberculosis.

Identification of genes of Mycobacterium tuberculosis upregulated during anaerobic persistence by fluorescence and kanamycin resistance selection.

V. Srivastava, B. S. Srivastava, A. Saxena, 2008, Tuberculosis.

Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli beta-galactosidase in Mycobacterium smegmatis and its implication in vaccine development.

B. S. Srivastava, Deepak Kumar, R. Srivastava, 1998, Vaccine.

Downregulation of Rv0189c, encoding a dihydroxyacid dehydratase, affects growth of Mycobacterium tuberculosis in vitro and in mice.

B. S. Srivastava, Vinayak Singh, R. Srivastava, 2011, Microbiology.

Identification of an antimicrobial entity from the cyanobacterium Fischerella sp. isolated from bark of Azadirachta indica (Neem) tree

Deepali, B. S. Srivastava, G. Nath, 2006, Journal of Applied Phycology.

Synthesis and biological evaluation of glycal-derived novel tetrahydrofuran 1,2,3-triazoles by 'click' chemistry.

P. Shukla, R. Srivastava, A. K. Shaw, 2010, Carbohydrate research.

Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection.

J. Kaper, B. S. Srivastava, R. Srivastava, 1993, Vaccine.

Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection.

J. Kaper, B. S. Srivastava, R. Srivastava, 1993, Vaccine.

Regulation of toxin biosynthesis by plasmids in Vibrio cholerae.

B. S. Srivastava, R. Srivastava, A. Khan, 1985, Journal of general microbiology.

Authors' response: on sialic acid transport and utilization by Vibrio cholerae

B. S. Srivastava, S. Sharma, R. Srivastava, 2011 .

Characterization of a novel cellobiase fromBacillussubtilis and expression of its structural gene inEscherichiacoli

A. Srivastava, R. Srivastava, A. Srivastava, 1990, Biotechnology Letters.

Characterization of a bacterial xylanase resistant to repression by glucose and xylose

A. Srivastava, R. Srivastava, A. Srivastava, 1993, Biotechnology Letters.

Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents.

A. Gaikwad, A. Srivastava, P. Shukla, 2004, Bioorganic & medicinal chemistry letters.

Immunological detection of cloned antigenic genes of Vibrio cholerae in Escherichia coli.

B. S. Srivastava, R. Srivastava, A. Khan, 1985, Gene.

Isolation and identification of a new antibacterial entity from the Antarctic cyanobacterium Nostoc CCC 537

Deepali, B. S. Srivastava, M. Tripathi, 2009, Journal of Applied Phycology.

Diaryloxy methano phenanthrenes: a new class of antituberculosis agents.

Shagufta, B. S. Srivastava, J. Mishra, 2004, Bioorganic & medicinal chemistry.

Manipulation of BCG vaccine: a double-edged sword

V. Singh, B. S. Srivastava, R. Srivastava, 2016, European Journal of Clinical Microbiology & Infectious Diseases.

Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models.

B. S. Srivastava, R. Srivastava, M. P. Dubey, 1998, Biochemical and biophysical research communications.

Synthesis and antimycobacterial activity of 3,5-disubstituted thiadiazine thiones.

B. S. Srivastava, V. Tiwari, V. Chaturvedi, 2003, Bioorganic & medicinal chemistry.

4-[10-(Methoxy-benzyl)-anthracen-9-yl]-phenol derivatives as new antitubercular agents

B. S. Srivastava, J. Mishra, G. Panda, 2005 .

Synthesis and bioevaluation of glycosyl ureas as alpha-glucosidase inhibitors and their effect on mycobacterium.

R. Ahmad, B. S. Srivastava, V. Tiwari, 2003, Bioorganic & medicinal chemistry.

Higher acyclic nitrogen containing deoxy sugar derivatives: a new lead in the generation of antimycobacterial chemotherapeutics.

A. Bhaduri, B. S. Srivastava, R. Pathak, 2002, Bioorganic & medicinal chemistry.

Synthesis and Anti-tubercular Activities of Benzo[4,5]furo[2,3-c] Chromen -6-one Derivatives

K. A. Kumar, S. Sinha, R. Srivastava, 2012 .

Baylis-Hillman reaction: convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents.

A. Gaikwad, A. Bhaduri, B. S. Srivastava, 2002, Bioorganic & medicinal chemistry.

C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.

Ram Sagar, Yenamandra S Prabhakar, Y. S. Prabhakar, 2007, Journal of medicinal chemistry.

Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.

Y. S. Prabhakar, M. Saquib, P. Shukla, 2014, European journal of medicinal chemistry.

2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.

M. Saquib, B. S. Srivastava, G. K. Jain, 2011, European journal of medicinal chemistry.

Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening.

B. S. Srivastava, S. Bhakta, S. Kundu, 2009, The Journal of antimicrobial chemotherapy.

Variable-number tandem repeat 3690 polymorphism in Indian clinical isolates of Mycobacterium tuberculosis and its influence on transcription.

Sarman Singh, P. Bifani, B. S. Srivastava, 2009, Journal of medical microbiology.

Improved laboratory diagnosis of tuberculosis--the Indian experience.

R. Kashyap, G. Taori, H. Daginawala, 2011, Tuberculosis.

Constitutive production of interleukin-8 (IL-8) by normal and malignant human B-cells and other cell types.

R. Srivastava, B. Srivastava, M. Srivastava, 1993, Leukemia research.

Synthesis and antimycobacterial activities of glycosylated amino alcohols and amines.

A. Gaikwad, B. S. Srivastava, V. Tiwari, 2005, European journal of medicinal chemistry.

Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents.

A. Gaikwad, P. Shukla, B. S. Srivastava, 2004, Bioorganic & medicinal chemistry letters.

Increased virulence of Mycobacterium tuberculosis H37Rv overexpressing LipY in a murine model.

B. S. Srivastava, M. P. Singh, A. Dasgupta, 2014, Tuberculosis.

Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.

B. S. Srivastava, R. Mazumder, J. Kundu, 2009, FEMS immunology and medical microbiology.

Enteroaggregative Escherichia coli and Salmonella associated with nondysenteric persistent diarrhea

S. Sazawal, H. Sommerfelt, P. Raj, 1989, The Pediatric infectious disease journal.

Rv3303c of Mycobacterium tuberculosis protects tubercle bacilli against oxidative stress in vivo and contributes to virulence in mice.

B. S. Srivastava, M. Srivastava, P. Akhtar, 2006, Microbes and infection.

Resuscitation Promoting Factors: a Family of Microbial Proteins in Survival and Resuscitation of Dormant Mycobacteria

R. Gupta, R. Srivastava, 2012, Indian Journal of Microbiology.

recA mutations reduce adherence and colonization by classical and El Tor strains of Vibrio cholerae.

K. Kumar, J. Kaper, B. S. Srivastava, 1994, Microbiology.

Screening of TnphoA mutants of Vibrio cholerae O139 for identification of antigens involved in colonisation.

B S Srivastava, B. S. Srivastava, V P Bondre, 1997, Journal of medical microbiology.

Events in the pathogenesis of experimental cholera: role of bacterial adherence and multiplication.

B. S. Srivastava, R. Srivastava, V. B. Sinha, 1980, Journal of medical microbiology.

Isolation of a non-adhesive mutant of Vibrio cholerae and chromosomal localization of the gene controlling mannose-sensitive adherence.

B. S. Srivastava, R. Srivastava, 1980, Journal of General Microbiology.

Attenuated recombinant strains of Vibrio cholerae for oral immunization.

B. S. Srivastava, R. Srivastava, V. B. Sinha, 1979, Bulletin of the World Health Organization.

Chromosomal transfer and in vivo cloning of genes in Vibrio cholerae using RP4::mini-Mu.

B. S. Srivastava, R. Srivastava, V. B. Sinha, 1989, Gene.

Prospects of Immunization Against Cholera by Adhesive Antigen

B. S. Srivastava, R. Srivastava, A. Jacob, 1989 .

Re-evaluation of antibacterial and antitoxin immunities in experimental cholera.

B. S. Srivastava, R. Srivastava, V. B. Sinha, 1979, The Indian journal of medical research.

Macrophage-specific Mycobacterium tuberculosis genes: identification by green fluorescent protein and kanamycin resistance selection.

C. Locht, V. Srivastava, B. S. Srivastava, 2007, Microbiology.

Identification of a repetitive sequence belonging to a PPE gene of Mycobacterium tuberculosis and its use in diagnosis of tuberculosis.

B. S. Srivastava, Meera Sharma, V. Katoch, 2006, Journal of medical microbiology.

RecombinantMycobacterium aurumExpressingEscherichia coliβ-Galactosidase in High Throughput Screening of Antituberculosis Drugs

B. S. Srivastava, Deepak Kumar, R. Srivastava, 1997 .

Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.

A. Saxena, V. Chaturvedi, Supriya Singh, 2011, Bioorganic & medicinal chemistry letters.

Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice.

V. Srivastava, B. S. Srivastava, A. Dwivedi, 2011, Vaccine.

Deoxysugars as Antituberculars and Alpha-Mannosidase Inhibitors

M. Saquib, V. Kashyap, Smriti Sharma, 2014, Antimicrobial Agents and Chemotherapy.

Application of 2D-DIGE in Identification of Differentially Expressed Proteins of Mycobacterium Bovis BCG in Nonculturable and Rpf Mediated Resuscitation Phase

T. Singh, B. S. Srivastava, A. Yadav, 2017 .

Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.

D. Deb, B. S. Srivastava, R. Srivastava, 2000, Biochemical and biophysical research communications.

Green Fluorescent Protein as a Reporter in Rapid Screening of Antituberculosis Compoundsin Vitroand in Macrophages

C. Locht, D. Deb, B. S. Srivastava, 1998 .

Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages.

C. Locht, D. Deb, B. S. Srivastava, 1998, Biochemical and biophysical research communications.

Recombinant Mycobacterium aurum expressing Escherichia coli beta-galactosidase in high throughput screening of antituberculosis drugs.

B. S. Srivastava, R. Srivastava, D. Kumar, 1997, Biochemical and biophysical research communications.

Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach.

B S Srivastava, D. Deb, B. S. Srivastava, 2002, Tuberculosis.

Cloning of xylanase gene of Streptomyces flavogriseus in Escherichia coli and bacteriophage lambda-induced lysis for the release of cloned enzyme.

B. S. Srivastava, S. Ali, R. Srivastava, 1991, FEMS microbiology letters.

Identification and characterisation of small-molecule inhibitors of Rv3097c-encoded lipase (LipY) of Mycobacterium tuberculosis that selectively inhibit growth of bacilli in hypoxia.

L. Kremer, A. Saxena, B. S. Srivastava, 2013, International journal of antimicrobial agents.

3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase.

M. Saquib, M. Siddiqi, P. Shah, 2015, Bioorganic chemistry.

Resuscitation Promoting Factors: a Family of Microbial Proteins in Survival and Resuscitation of Dormant Mycobacteria

R. Gupta, R. Srivastava, 2011, Indian Journal of Microbiology.

Defining New Drug Targets Through Protein-Protein Interaction: Interaction of Resuscitation Promoting Factors with SucA of TCA Cycle in M. tuberculosis H37Rv

B. S. Srivastava, R. Gupta, R. Srivastava, 2016 .

Differential Expression of Proteins of Mycobacterium bovis BCG during Adaptation to Anaerobic Non Replicating Persistence

B. S. Srivastava, A. Saxena, R. Srivastava, 2018 .

Identification of a 25-kilodalton protein of Mycobacterium bovis BCG to distinguish BCG strains from Mycobacterium tuberculosis

B. S. Srivastava, R. Srivastava, D. Kumar, 1996, Journal of Clinical Microbiology.